These success, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the concept of targeting ACKR3 as a unique method to modulate the opioid process, which could open new therapeutic avenues for opioid-associated disorders. In combination with the explained previously https://hermannu161fjk0.blogadvize.com/profile